Somatostatin receptor imaging in small cell lung cancer

Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients

1993 • 1,563 citations

Staging and prognostic factors in small cell lung cancer: a consensus report

1989 • 256 citations

Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumours

1994 • 190 citations

Somatostatin receptors and somatostatin content in medullary thyroid carcinomas.

1991 • 130 citations

The value of octreotide scintigraphy in patients with lung cancer

1994 • 101 citations

Importance of clinical staging in limited small-cell lung cancer: a valuable system to separate prognostic subgroups. The University of Toronto Lung Oncology Group.

1993 • 78 citations

Experimental and clinical studies with somatostatin analogue octreotide in small cell lung cancer

1991 • 75 citations

Somatostatin receptor scintigraphy in forty-eight patients with the Zollinger-Ellison syndrome

1994 • 71 citations

Response of human lung tumor xenografts to treatment with a somatostatin analogue (Somatuline).

1990 • 61 citations

Indium-111 pentetreotide in the diagnostic work-up of patients with bronchogenic carcinoma

1994 • 49 citations

Scintigraphic imaging of lung tumours with a radiolabelled somatostatin analogue

1993 • 4 citations

3. Imaging and therapy control of tumours by receptor scintigraphy with 111In-octreotide

1993 • 3 citations